Proksimal üreter taşı olan 96 olguda ESWL tedavisi sonuçları

Cilt: 54 Sayı: 1 1 Mart 2015
  • Tufan Süelözgen
  • Hakan Türk
  • Cemal Selçuk İşoğlu
  • Mehmet Yoldaş
  • Mustafa Karabıçak
  • Batuhan Ergani
  • Yusuf Özlem İlbey
  • Ferruh Zorlu
PDF İndir
EN TR

ESWL treatment results of 96 patients with proximal ureter stone

Öz

Aim: Extracorporeal shock wave lithotripsy (ESWL) is a favourable and succesful treatment method for ureter stones. It is highlighted that ESWL can be the first treatment choice for ureter stones. In this study, the results of patients who had ESWL treatment for proximal ureter stones were examined in the light of pertinent literature. Materials and Methods: Between January 2013-January 2014, ESWL is proposed to 114 patients who had proximal ureter stone and who didn't benefit from medical treatment. Since eighteen patients could not be followed, 96 patients were included in the study. All patients evaluated with non-contrast computed tomography (NCCT). Average stone size was 9.42 mm (5-16 mm) and all them were opaque. All patients had ESWL treatment for 3 session with 60 frequency per minute, with a 17-20 kV power and 2500 beats per session. After 3 sessions of ESWL, the patients who finished whole treatment were evaluated with NCCT to assess the success of treatment after a waiting period of one month. Results: ESWL was successful in 69 (69.79%) patients. In 29 (30.21%) patients there was no change in stone size, so ureterorenoscopy was suggested. Success status was evaluated regarding stone size. Stones were completely fragmanted in 42 (79.2%) of 53 patients who had stones with a dimension of 1 cm or less, and in 25 (%58.1) of 43 patients who had stones with a dimension greater than 1 cm. Conclusion: ESWL can be considered as a relatively low-cost, non-invasive, reliable and succesful method of treatment for ureter stones.

Anahtar Kelimeler

Ayrıntılar

Birincil Dil

Türkçe

Konular

-

Bölüm

-

Yazarlar

Tufan Süelözgen

Hakan Türk

Cemal Selçuk İşoğlu

Mehmet Yoldaş

Mustafa Karabıçak

Batuhan Ergani

Yusuf Özlem İlbey

Ferruh Zorlu

Yayımlanma Tarihi

1 Mart 2015

Gönderilme Tarihi

1 Mart 2015

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2015 Cilt: 54 Sayı: 1

Kaynak Göster

APA
Süelözgen, T., Türk, H., İşoğlu, C. S., Yoldaş, M., Karabıçak, M., Ergani, B., İlbey, Y. Ö., & Zorlu, F. (2015). Proksimal üreter taşı olan 96 olguda ESWL tedavisi sonuçları. Ege Tıp Dergisi, 54(1), 1-3. https://doi.org/10.19161/etd.344098
AMA
1.Süelözgen T, Türk H, İşoğlu CS, vd. Proksimal üreter taşı olan 96 olguda ESWL tedavisi sonuçları. ETD. 2015;54(1):1-3. doi:10.19161/etd.344098
Chicago
Süelözgen, Tufan, Hakan Türk, Cemal Selçuk İşoğlu, vd. 2015. “Proksimal üreter taşı olan 96 olguda ESWL tedavisi sonuçları”. Ege Tıp Dergisi 54 (1): 1-3. https://doi.org/10.19161/etd.344098.
EndNote
Süelözgen T, Türk H, İşoğlu CS, Yoldaş M, Karabıçak M, Ergani B, İlbey YÖ, Zorlu F (01 Mart 2015) Proksimal üreter taşı olan 96 olguda ESWL tedavisi sonuçları. Ege Tıp Dergisi 54 1 1–3.
IEEE
[1]T. Süelözgen vd., “Proksimal üreter taşı olan 96 olguda ESWL tedavisi sonuçları”, ETD, c. 54, sy 1, ss. 1–3, Mar. 2015, doi: 10.19161/etd.344098.
ISNAD
Süelözgen, Tufan - Türk, Hakan - İşoğlu, Cemal Selçuk - Yoldaş, Mehmet - Karabıçak, Mustafa - Ergani, Batuhan - İlbey, Yusuf Özlem - Zorlu, Ferruh. “Proksimal üreter taşı olan 96 olguda ESWL tedavisi sonuçları”. Ege Tıp Dergisi 54/1 (01 Mart 2015): 1-3. https://doi.org/10.19161/etd.344098.
JAMA
1.Süelözgen T, Türk H, İşoğlu CS, Yoldaş M, Karabıçak M, Ergani B, İlbey YÖ, Zorlu F. Proksimal üreter taşı olan 96 olguda ESWL tedavisi sonuçları. ETD. 2015;54:1–3.
MLA
Süelözgen, Tufan, vd. “Proksimal üreter taşı olan 96 olguda ESWL tedavisi sonuçları”. Ege Tıp Dergisi, c. 54, sy 1, Mart 2015, ss. 1-3, doi:10.19161/etd.344098.
Vancouver
1.Tufan Süelözgen, Hakan Türk, Cemal Selçuk İşoğlu, Mehmet Yoldaş, Mustafa Karabıçak, Batuhan Ergani, Yusuf Özlem İlbey, Ferruh Zorlu. Proksimal üreter taşı olan 96 olguda ESWL tedavisi sonuçları. ETD. 01 Mart 2015;54(1):1-3. doi:10.19161/etd.344098

Ege Tıp Dergisi, makalelerin Atıf-Gayri Ticari-Aynı Lisansla Paylaş 4.0 Uluslararası (CC BY-NC-SA 4.0) lisansına uygun bir şekilde paylaşılmasına izin verir.